These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 15371665)

  • 1. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade.
    Turgeon NA; Iwakoshi NN; Phillips NE; Meyers WC; Welsh RM; Greiner DL; Mordes JP; Rossini AA
    J Surg Res; 2000 Sep; 93(1):63-9. PubMed ID: 10945944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
    Markees TG; Pearson T; Cuthbert A; Pearson AL; Shultz LD; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    Transplantation; 2004 Dec; 78(11):1601-8. PubMed ID: 15591948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells.
    Gordon EJ; Woda BA; Shultz LD; Rossini AA; Greiner DL; Mordes JP
    Transplantation; 2001 Jan; 71(2):319-27. PubMed ID: 11213080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
    Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.
    Song HK; Alters SE; Fathman CG
    Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells.
    Nasr IW; Wang Y; Gao G; Deng S; Diggs L; Rothstein DM; Tellides G; Lakkis FG; Dai Z
    J Immunol; 2005 May; 174(10):6161-8. PubMed ID: 15879112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
    J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.
    Mangada J; Pearson T; Brehm MA; Wicker LS; Peterson LB; Shultz LD; Serreze DV; Rossini AA; Greiner DL
    Diabetes; 2009 Jan; 58(1):165-73. PubMed ID: 18984741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av; Herber M; Wood KJ; Jones ND
    J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways.
    Nicolls MR; Coulombe M; Beilke J; Gelhaus HC; Gill RG
    J Immunol; 2002 Nov; 169(9):4831-9. PubMed ID: 12391193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
    J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.